.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Cipla
Fuji
Baxter
Medtronic
Deloitte
Chubb
Julphar
Cerilliant

Generated: December 13, 2017

DrugPatentWatch Database Preview

Drug Master Files for: CEPHALOTHIN SODIUM

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
12586AII7/9/1997ACS DOBFAR SPACEPHALOTHIN SODIUM, ORAL GRADE
13206III4/30/1998ACS DOBFAR SPACEPHALOTHIN SODIUM
13384III9/1/1998LILLY RESEARCH LABORATORIESCEPHALOTHIN SODIUM
19983AII11/16/2006AUROBINDO PHARMA LTDCEPHALOTHIN ACID (NON-STERILE DRUG SUBSTANCE INTERMEDIATE)
24679AII2/25/2011PARABOLIC DRUGS LTDCEPHALOTHIN SODIUM (STERILE) BUFFERED (USP)
13545III9/1/1998ANTIBIOTICOS INCCEPHALOTHIN SODIUM;SODIUM CHLORIDE
13546III9/1/1998ANTIBIOTICOS INCCEPHALOTHIN SODIUM;SODIUM CHLORIDE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Baxter
US Department of Justice
Dow
Novartis
QuintilesIMS
Queensland Health
Harvard Business School
Argus Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot